These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20701407)
1. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD. Charlton RA; Weil JG; Cunnington MC; de Vries CS Drug Saf; 2010 Sep; 33(9):741-50. PubMed ID: 20701407 [TBL] [Abstract][Full Text] [Related]
2. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222 [TBL] [Abstract][Full Text] [Related]
3. Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries. Charlton RA; Cunnington MC; de Vries CS; Weil JG Drug Saf; 2008; 31(1):39-51. PubMed ID: 18095745 [TBL] [Abstract][Full Text] [Related]
4. Positive predictive value of computerized records for major congenital malformations. Cooper WO; Hernandez-Diaz S; Gideon P; Dyer SM; Hall K; Dudley J; Cevasco M; Thompson AB; Ray WA Pharmacoepidemiol Drug Saf; 2008 May; 17(5):455-60. PubMed ID: 18081215 [TBL] [Abstract][Full Text] [Related]
5. The utility of the general practice research database to examine selected congenital heart defects: a validation study. Wurst KE; Ephross SA; Loehr J; Clark DW; Guess HA Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):867-77. PubMed ID: 17563909 [TBL] [Abstract][Full Text] [Related]
6. Preliminary results on pregnancy outcomes in women using lamotrigine. Tennis P; Eldridge RR; Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730 [TBL] [Abstract][Full Text] [Related]
7. Anticonvulsants and congenital malformations. Jick SS; Terris BZ Pharmacotherapy; 1997; 17(3):561-4. PubMed ID: 9165559 [TBL] [Abstract][Full Text] [Related]
8. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview. Charlton R; Snowball J; Sammon C; de Vries C Therapie; 2014; 69(1):83-9. PubMed ID: 24698192 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens. Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217 [TBL] [Abstract][Full Text] [Related]
10. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L; BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116 [TBL] [Abstract][Full Text] [Related]
11. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010. Deck GM; Nadkarni N; Montouris GD; Lovett A Epilepsy Behav; 2015 Oct; 51():166-9. PubMed ID: 26283306 [TBL] [Abstract][Full Text] [Related]
12. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. Johansson S; Wallander MA; de Abajo FJ; García Rodríguez LA Drug Saf; 2010 Mar; 33(3):223-32. PubMed ID: 20158286 [TBL] [Abstract][Full Text] [Related]
13. Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland. Artama M; Ritvanen A; Gissler M; Isojärvi J; Auvinen A Int J Epidemiol; 2006 Apr; 35(2):280-7. PubMed ID: 16280367 [TBL] [Abstract][Full Text] [Related]
14. Clonazepam use in pregnancy and the risk of malformations. Lin AE; Peller AJ; Westgate MN; Houde K; Franz A; Holmes LB Birth Defects Res A Clin Mol Teratol; 2004 Aug; 70(8):534-6. PubMed ID: 15329832 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in three cases after brivaracetam treatment during pregnancy. Paolini SL; Pilato M; Rajasekaran V; Waters JFR; Bagic A; Urban A Acta Neurol Scand; 2020 May; 141(5):438-441. PubMed ID: 31943124 [TBL] [Abstract][Full Text] [Related]
17. Using ICD-9 codes to establish prevalence of malformations in newborn infants. Holmes LB; Westgate MN Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):208-14. PubMed ID: 22451461 [TBL] [Abstract][Full Text] [Related]
18. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research. Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959 [TBL] [Abstract][Full Text] [Related]
19. Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection. de Jonge L; Zetstra-van der Woude PA; Bos HJ; de Jong-van den Berg LT; Bakker MK Drug Saf; 2013 Nov; 36(11):1069-78. PubMed ID: 23828658 [TBL] [Abstract][Full Text] [Related]
20. Malformations in offspring of women with epilepsy: a prospective study. Canger R; Battino D; Canevini MP; Fumarola C; Guidolin L; Vignoli A; Mamoli D; Palmieri C; Molteni F; Granata T; Hassibi P; Zamperini P; Pardi G; Avanzini G Epilepsia; 1999 Sep; 40(9):1231-6. PubMed ID: 10487185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]